Kizzmekia Corbett

Dr. Kizzmekia Corbett is an Assistant Professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health, where she leads groundbreaking research in viral immunology and vaccine development for pandemic preparedness. She gained international recognition for her pivotal role in developing the mRNA-1273 vaccine against SARS-CoV-2, which demonstrated 94.1% effectiveness in Phase 3 clinical trials.

Dr. Corbett's research spans multiple critical areas in virology and immunology:

• Viral immunology and host-pathogen interactions
• mRNA vaccine platform development
• Structural biology of viral spike proteins
• Development of universal coronavirus and influenza vaccines
• Therapeutic antibody development

Analysis of Dr. Corbett's publication record reveals a strong focus on stabilizing viral spike proteins in prefusion conformations to elicit potent immune responses. Her work bridges structural biology, immunology, and translational research, with numerous studies utilizing non-human primate models to evaluate vaccine efficacy. A significant portion of her recent work focuses on developing broadly protective vaccines that can provide immunity against multiple variants and related viruses, representing a paradigm shift in pandemic preparedness.

Dr. Corbett's contributions have been recognized with prestigious awards including:

• Benjamin Franklin Next Gen Award
• Salzman Memorial Award in Virology

Dr. Corbett combines her research expertise with a strong commitment to mentorship and community engagement. She actively invests time in underserved communities as an advocate for STEM education and vaccine awareness, using her platform to promote scientific literacy and address vaccine hesitancy. Her research program at Harvard continues to advance the frontiers of viral immunology while maintaining a strong focus on translating scientific discoveries into practical public health solutions for emerging viral threats.